University of Utah College of Nursing, Salt Lake City, UT, USA.
Primary Children's Hospital, Center for Cancer and Blood Disorders, Salt Lake City, UT, USA.
J Pediatr Hematol Oncol Nurs. 2023 Mar-Apr;40(2):69-81. doi: 10.1177/27527530221122683. Epub 2022 Nov 10.
Despite initiatives to reduce central line-associated bloodstream infection (CLABSI), children and adolescents with hematologic malignancies, as well as those with relapsed disease, remain at the greatest risk for infection. This single-institution project evaluated changes in CLABSI rates following implementation of antibacterial prophylaxis with levofloxacin for patients with high-risk hematologic malignancies. Positive blood culture events meeting National Health Safety Network surveillance criteria to be classified as CLABSIs from January 1, 2006, to December 31, 2019, were included. Data were organized into four time periods for comparison based on implementation of CLABSI-reduction interventions. Conditional Poisson regression models were used to evaluate the effect of time (intervention period) on CLABSI rates with post hoc Tukey pairwise comparisons between each of the four time periods. From 2006 and 2019, 227 patients experienced 310 CLABSIs. Clinically important decreases in CLABSI rates from baseline (4.84 per 1,000 line days) occurred with implementation of Children's Hospital Association (CHA) bundles (3.29 per 1,000 line days); however, this difference was not significant ( = .16). CLABSI rates decreased from baseline with the addition of formalized supportive cares (2.66 per 1,000 line days; incidence rate ratio [IRR] = 0.60; < .01), and with the use of antibacterial prophylaxis (1.66 per 1,000 line days; IRR = 0.35; < .01). Post hoc comparisons indicated decreased CLABSI rates with the use of antibacterial prophylaxis compared with CHA bundles alone (IRR = 0.49; = .011) and CHA bundles plus formalized supportive cares (IRR = 0.58; = .046). Results demonstrate sustained success using a practice-based evidence approach to guide CLABSI-reduction interventions. Follow-up research, applying machine learning algorithms, may identify additional risk factors and inform future interventions.
尽管采取了减少中心静脉相关血流感染 (CLABSI) 的措施,但患有血液系统恶性肿瘤的儿童和青少年,以及那些疾病复发的患者,仍然面临最大的感染风险。本机构单中心项目评估了左氧氟沙星预防抗菌治疗用于高危血液系统恶性肿瘤患者后 CLABSI 发生率的变化。纳入符合国家卫生安全网络监测标准的血培养阳性事件,定义为 2006 年 1 月 1 日至 2019 年 12 月 31 日期间的 CLABSI。数据根据 CLABSI 减少干预措施的实施情况分为四个时间段进行比较。采用条件泊松回归模型评估时间(干预期)对 CLABSI 发生率的影响,并对四个时间段之间的每个时间段进行事后 Tukey 两两比较。从 2006 年至 2019 年,227 例患者发生 310 例 CLABSI。实施儿童保健协会 (CHA) 捆绑包后,CLABSI 率从基线水平(每 1000 个导管日 4.84 例)显著下降(每 1000 个导管日 3.29 例);然而,差异无统计学意义( = .16)。随着正式支持护理的增加(每 1000 个导管日 2.66 例;发病率比 [IRR] = 0.60; < .01)和抗菌预防(每 1000 个导管日 1.66 例;IRR = 0.35; < .01),CLABSI 率从基线水平下降。事后比较表明,与仅使用 CHA 捆绑包(IRR = 0.49; = .011)和 CHA 捆绑包加正式支持护理(IRR = 0.58; = .046)相比,使用抗菌预防可降低 CLABSI 率。结果表明,采用基于实践的证据方法指导 CLABSI 减少干预措施取得了持续成功。后续研究应用机器学习算法可能会发现其他危险因素,并为未来的干预措施提供信息。